For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Study
Spam, That Ill O’ The ISP
Full Document Available in PDF Most public attention has been focused on…
Op-Eds
Time for the GM Moratorium to Go
After months of anticipation, the U.S. government is expected to file a formal complaint today with the World Trade Organization against the European Union’s five-year…
News Release
Biotech Trade Challenge a Boon for Developing World
Washington, D.C., May 13, 2003—The Competitive Enterprise Institute applauds today’s announcement by the Office of the U.S. Trade Representative that it, along with Canada, Argentina,…
News Release
Scientists Urge European Union to End Biotech Food Ban
Contact for Interviews: <?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Richard Morrison, 202.331.2273 <?xml:namespace prefix…
Op-Eds
Utopian Policymaking: The Inherent Dangers of “Inherently Safer Technology”
What would you say if the federal government proposed phasing out large commercial airplanes? After all, they could argue that using only small planes with…
News Release
Should FDA Force Switching of Rx Drugs to OTC?
<?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” /> Contact for Interviews: <?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” />…